-+ 0.00%
-+ 0.00%
-+ 0.00%

Reviva Pharmaceuticals Q1 EPS $(0.46) Beats $(0.62) Estimate

Benzinga·05/13/2026 20:39:25
Listen to the news
Reviva Pharmaceuticals (NASDAQ:RVPH) reported quarterly losses of $(0.46) per share which beat the analyst consensus estimate of $(0.62) by 25.81 percent. This is a 82.31 percent increase over losses of $(2.60) per share from the same period last year.